Advancing Healthcare with Innovation & Quality | Trusted Pharma Solutions for a Healthier Tomorrow
Product Launch Announcement: Lorsoft 10 (Loratadine 10mg) tablets We are proud to introduce Lorsoft 10 contains Loratadine 10mg, a second-generation, non-sedating antihistamine designed to provide effective relief from allergy symptoms. It helps manage allergic rhinitis and chronic urticaria while allowing patients to maintain their daily activities with minimal drowsiness. 🔍 Product Overview Generic Name: Loratadine Strength:…
Product Launch Announcement: Lecetzine 5 (Levocetirizine 5 mg) tablets We are proud to introduce Lecetzine 5 contains Levocetirizine 5 mg, a second-generation antihistamine indicated for the effective management of allergic conditions. It helps relieve symptoms such as sneezing, runny nose, itchy eyes, and skin allergies, providing dependable relief and improved patient comfort. 🔍 Product Overview Generic…
Product Launch Announcement: Fexorelief 120 (Fexofenadine 120mg) tablets We are proud to introduce Fexorelief 120 contains Fexofenadine 120mg, a second-generation, non-sedating antihistamine used for the relief of allergy symptoms. It provides effective, long-lasting relief from symptoms associated with allergic rhinitis while helping patients maintain their normal daily activities. 🔍 Product Overview Generic Name: Fexofenadine Strength: 120mg…
Product Launch Announcement: Ebarelief 20 (Ebastine 20mg) tablets We are proud to introduce Ebarelief 20 contains Ebastine 20mg, a second-generation antihistamine used for the management of allergic conditions. It helps relieve common allergy symptoms such as sneezing, runny nose, itching, watery eyes, and urticaria. 🔍 Product Overview Generic Name: Ebastine Strength: 20mg Formulation: Tablets Primary Indications:…
Product Launch Announcement: Desloclear 5 (Desloratadine 5mg) tablets We are proud to introduce Desloclear 5 contains Desloratadine 5mg, a second-generation, non-sedating antihistamine indicated for the effective treatment of allergic conditions. It offers rapid, long-lasting relief from allergy symptoms with once-daily dosing while helping patients maintain their daily routine without significant drowsiness. 🔍 Product Overview Generic Name:…
Product Launch Announcement: Bilafaith 20 (Bilastine 20mg) tablets We are proud to introduce Bilafaith 20 contains Bilastine 20 mg, a second-generation, non-sedating antihistamine indicated for the effective management of allergic conditions. It provides rapid and long-lasting relief from allergy symptoms while maintaining alertness and minimizing drowsiness. 🔍 Product Overview Generic Name: Bilastine Strength: 20mg Formulation: Tablets…
Product Launch Announcement: Lucavorin 15 (Leucovorin Calcium 15mg) tablets We are proud to introduce Lucavorin 15 contains Leucovorin Calcium 15mg, an oral folate analogue used as a rescue therapy following high-dose methotrexate treatment and as an adjunct to specific chemotherapy regimens. It also plays an important role in reducing the toxic effects of folate antagonist therapy…
Product Launch Announcement: Epag 50 (Eltrombopag Olamine 50mg) tablets We are proud to introduce Epag 50 contains Eltrombopag Olamine 50mg, an oral thrombopoietin receptor agonist (TPO-RA) used to increase platelet production in patients with selected hematological disorders. It is indicated for appropriate patients with chronic immune thrombocytopenia (ITP), severe aplastic anemia (SAA), and certain cases of…
Product Launch Announcement: Lenaliheal 25 (Lenalidomide 10mg) capsules We are proud to introduce Lenaliheal 25 contains Lenalidomide 25 mg, an oral immunomodulatory agent (IMiD®) used in the treatment of selected hematological malignancies. It is indicated for appropriate patients with conditions such as multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and certain types of lymphoma, in…
Product Launch Announcement: Lenaliheal 10 (Lenalidomide 10mg) capsules We are proud to introduce Lenaliheal 10 contains Lenalidomide 10 mg, an oral immunomodulatory agent (IMiD®) used in the treatment of selected hematological malignancies. It is indicated for appropriate patients with conditions such as multiple myeloma, myelodysplastic syndromes (MDS) with deletion 5q, and certain types of lymphoma, in…
End of content
End of content
WhatsApp us
